RecallDepth
Class II Ongoing

Clindamycin Hydrochloride Capsules, USP, 300mg, 30-count bottles, Manufactured by: Glenmark Pharmaceuticals Limited, NDC 68788-8685-03.

Company
Preferred Pharmaceuticals, Inc.
Recall Initiated
April 18, 2025
Posted
May 7, 2025
Recall Number
D-0391-2025
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
1190 Bottles
Firm Location
Anaheim, CA, United States

Reason for Recall

cGMP Deviations

Distribution

Nationwide in the US

Lot / Code Info

Lot #: L0224T, K1824M, K0124N, J1624V, J0824O, I2424E, I1024O, A0925F, L2324L, Exp: 7/31/2026.

More recalls by Preferred Pharmaceuticals, Inc.

View all recalls by this company →

Other recent Class II Drug recalls